Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging

To demonstrate the feasibility of using DNP hyperpolarized [1‐13C]‐pyruvate to measure early response to temozolomide (TMZ) therapy using an orthotopic human glioblastoma xenograft model.

[1]  Ilwoo Park,et al.  Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors. , 2010, Neuro-oncology.

[2]  Michael Lustig,et al.  3D compressed sensing for highly accelerated hyperpolarized 13C MRSI with in vivo applications to transgenic mouse models of cancer , 2010, Magnetic resonance in medicine.

[3]  Albert P. Chen,et al.  Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. , 2008, Cancer research.

[4]  J. Ardenkjaer-Larsen,et al.  Dynamic Nuclear Polarization with Trityls at 1.2 K , 2008 .

[5]  P. Maingon,et al.  Temozolomide and radiotherapy antitumor efficacy evaluation with magnetic resonance imaging and proton magnetic resonance spectroscopy in human glioma models in nude rats , 2008 .

[6]  Peter Magnusson,et al.  Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI , 2008, Magnetic resonance in medicine.

[7]  P. Kavan,et al.  When Temozolomide Alone Fails: Adding Procarbazine in Salvage Therapy of Glioma , 2008, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[8]  John M Pauly,et al.  Hyperpolarized C‐13 spectroscopic imaging of the TRAMP mouse at 3T—Initial experience , 2007, Magnetic resonance in medicine.

[9]  Jan Wolber,et al.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy , 2007, Nature Medicine.

[10]  B. Ross,et al.  Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  John M Pauly,et al.  Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. , 2007, Journal of magnetic resonance.

[12]  N. Tomura,et al.  Diffusion Changes in a Tumor and Peritumoral Tissue After Stereotactic Irradiation for Brain Tumors: Possible Prediction of Treatment Response , 2006, Journal of computer assisted tomography.

[13]  R. Meuli,et al.  Perfusion and diffusion MRI of glioblastoma progression in a four-year prospective temozolomide clinical trial. , 2006, International Journal of Radiation Oncology, Biology, Physics.

[14]  John M Pauly,et al.  Design of flyback echo‐planar readout gradients for magnetic resonance spectroscopic imaging , 2005, Magnetic resonance in medicine.

[15]  R. DeLaPaz,et al.  Multisection 1H Magnetic Resonance Spectroscopic Imaging Assessment of Glioma Response to Chemotherapy , 2005, Journal of Neuro-Oncology.

[16]  A. Brandes,et al.  Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Tom Mikkelsen,et al.  Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: Quality and analysis results of a phase I trial , 2004, Journal of magnetic resonance imaging : JMRI.

[18]  Mark Muzi,et al.  Positron emission tomography imaging of brain tumors. , 2003, Neuroimaging clinics of North America.

[19]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Walecki,et al.  Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method. , 2003, Academic radiology.

[21]  S. Gambhir.  Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[22]  S. Nelson.  Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors , 2001, Magnetic resonance in medicine.

[23]  F. Jolesz,et al.  Gradient-Echo Imaging Considerations for Hyperpolarized 129Xe MR , 1996, Journal of magnetic resonance. Series B.

[24]  L Zhao,et al.  Gradientecho imaging considerations for hyperpolarized ^ Xe MR , 1996 .

[25]  T. Cascino,et al.  Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  C Hawryszko,et al.  Design and evaluation of a novel dual-tuned resonator for spectroscopic imaging , 1990 .